Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease.
作者： José Luis Ferreiro , Ángel R Cequier , Dominick J Angiolillo
关键词:
摘要: Currently approved antiplatelet treatment strategies have proved successful for reducing cardiovascular adverse events in patients with CAD. However, despite the use of recommended strategies, presence DM has been consistently associated a negative impact on outcomes and high rate continue to occur DM. The elevated prevalence low response standard oral agents contribute these impaired outcomes. Thus, search more potent is warranted high-risk patients, such as those present manuscript provides an overview current status knowledge currently available agents, focusing benefits limitations therapies evaluating potential role new antithrombotic under development overcome limitations.
sagepub.com
sci-hub.se 参考文章(136)
Dominick J. Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, Fernando Alfonso, Carlos Macaya, Theodore A. Bass, Marco A. Costa, Variability in Individual Responsiveness to Clopidogrel: Clinical Implications, Management, and Future Perspectives Journal of the American College of Cardiology. ,vol. 49, pp. 1505- 1516 ,(2007) , 10.1016/J.JACC.2006.11.044
Seung-Whan Lee, Seong-Wook Park, Young-Hak Kim, Sung-Cheol Yun, Duk-Woo Park, Cheol Whan Lee, Myeong-Ki Hong, Hyun-Sook Kim, Jae-Ki Ko, Jae-Hyeong Park, Jae-Hwan Lee, Si Wan Choi, In-Whan Seong, Yoon Haeng Cho, Nae-Hee Lee, June Hong Kim, Kook-Jin Chun, Seung-Jung Park, Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus: The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients) Journal of the American College of Cardiology. ,vol. 51, pp. 1181- 1187 ,(2008) , 10.1016/J.JACC.2007.11.049
The TRA•CER Executive and Steering Committees, The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA.CER) trial : study design and rationale American Heart Journal. ,vol. 158, pp. 327- 334 ,(2009) , 10.1016/J.AHJ.2009.07.001
Denis Clement, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events(CAPRIE). The Lancet. ,vol. 348, pp. 1329- 1339 ,(1996)
A. D. MICHELSON, M. CATTANEO, J. W. EIKELBOOM, P. GURBEL, K. KOTTKE-MARCHANT, T. J. KUNICKI, F. M. PULCINELLI, C. CERLETTI, A. K. RAO, , Aspirin resistance: position paper of the Working Group on Aspirin Resistance Journal of Thrombosis and Haemostasis. ,vol. 3, pp. 1309- 1311 ,(2005) , 10.1111/J.1538-7836.2005.01351.X
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. The New England Journal of Medicine. ,vol. 345, pp. 494- 502 ,(2001) , 10.1056/NEJMOA010746
Koon-Hou Mak, MBBS, David J Moliterno, MD, FACC, Christopher B Granger, MD, FACC, Dave P Miller, MS, Harvey D White, MB, DSc, FACC, Robert G Wilcox, MD, FACC, Robert M Califf, MD, FACC, Eric J Topol, MD, FACC, Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction Journal of the American College of Cardiology. ,vol. 30, pp. 171- 179 ,(1997) , 10.1016/S0735-1097(97)00118-6
Małgorzata Bartnik, Lars Ryden, Roberto Ferrari, Klas Malmberg, Kalevi Pyörälä, Maarten Simoons, Eberhard Standl, Jordi Soler-Soler, John Öhrvik, None, The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. European Heart Journal. ,vol. 25, pp. 1880- 1890 ,(2004) , 10.1016/J.EHJ.2004.07.027
Christian Gachet, None, ADP receptors of platelets and their inhibition. Thrombosis and Haemostasis. ,vol. 86, pp. 222- 232 ,(2001) , 10.1055/S-0037-1616220
Giovanni Davì, Isabella Catalano, Maurizio Averna, Alberto Notarbartolo, Antonio Strano, Giovanni Ciabattoni, Carlo Patrono, Thromboxane Biosynthesis and Platelet Function in Type II Diabetes Mellitus New England Journal of Medicine. ,vol. 322, pp. 1769- 1774 ,(1990) , 10.1056/NEJM199006213222503